Global Natural Killer Cells Therapeutics Market Size, Status and Forecast 2019-2025

SKU ID :QYR-13803722 | Published Date: 14-Aug-2019 | No. of pages: 99
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 NK Cell Therapies 1.4.3 NK Cell Directed Antibodies 1.5 Market by Application 1.5.1 Global Natural Killer Cells Therapeutics Market Share by Application (2019-2025) 1.5.2 Cancer 1.5.3 Gastrointestinal Diseases 1.5.4 Immunoproliferative Disorders 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Natural Killer Cells Therapeutics Market Size 2.2 Natural Killer Cells Therapeutics Growth Trends by Regions 2.2.1 Natural Killer Cells Therapeutics Market Size by Regions (2019-2025) 2.2.2 Natural Killer Cells Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Natural Killer Cells Therapeutics Market Size by by Players 3.1.1 Global Natural Killer Cells Therapeutics Revenue by by Players (2014-2019) 3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by by Players (2014-2019) 3.1.3 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Natural Killer Cells Therapeutics Key Players Head office and Area Served 3.3 Key Players Natural Killer Cells Therapeutics Product/Solution/Service 3.4 Date of Enter into Natural Killer Cells Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Natural Killer Cells Therapeutics Market Size by Type (2014-2019) 4.2 Global Natural Killer Cells Therapeutics Market Size by Application (2014-2019) 5 North America 5.1 North America Natural Killer Cells Therapeutics Market Size (2014-2019) 5.2 Natural Killer Cells Therapeutics Key Players in North America 5.3 North America Natural Killer Cells Therapeutics Market Size by Type 5.4 North America Natural Killer Cells Therapeutics Market Size by Application 6 Europe 6.1 Europe Natural Killer Cells Therapeutics Market Size (2014-2019) 6.2 Natural Killer Cells Therapeutics Key Players in Europe 6.3 Europe Natural Killer Cells Therapeutics Market Size by Type 6.4 Europe Natural Killer Cells Therapeutics Market Size by Application 7 China 7.1 China Natural Killer Cells Therapeutics Market Size (2014-2019) 7.2 Natural Killer Cells Therapeutics Key Players in China 7.3 China Natural Killer Cells Therapeutics Market Size by Type 7.4 China Natural Killer Cells Therapeutics Market Size by Application 8 Japan 8.1 Japan Natural Killer Cells Therapeutics Market Size (2014-2019) 8.2 Natural Killer Cells Therapeutics Key Players in Japan 8.3 Japan Natural Killer Cells Therapeutics Market Size by Type 8.4 Japan Natural Killer Cells Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Natural Killer Cells Therapeutics Market Size (2014-2019) 9.2 Natural Killer Cells Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Natural Killer Cells Therapeutics Market Size by Type 9.4 Southeast Asia Natural Killer Cells Therapeutics Market Size by Application 10 India 10.1 India Natural Killer Cells Therapeutics Market Size (2014-2019) 10.2 Natural Killer Cells Therapeutics Key Players in India 10.3 India Natural Killer Cells Therapeutics Market Size by Type 10.4 India Natural Killer Cells Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Natural Killer Cells Therapeutics Market Size (2014-2019) 11.2 Natural Killer Cells Therapeutics Key Players in Central & South America 11.3 Central & South America Natural Killer Cells Therapeutics Market Size by Type 11.4 Central & South America Natural Killer Cells Therapeutics Market Size by Application 12 International Players Profiles 12.1 Affimed 12.1.1 Affimed Company Details 12.1.2 Company Description and Business Overview 12.1.3 Natural Killer Cells Therapeutics Introduction 12.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2014-2019)) 12.1.5 Affimed Recent Development 12.2 Celgene 12.2.1 Celgene Company Details 12.2.2 Company Description and Business Overview 12.2.3 Natural Killer Cells Therapeutics Introduction 12.2.4 Celgene Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.2.5 Celgene Recent Development 12.3 Fate Therapeutics 12.3.1 Fate Therapeutics Company Details 12.3.2 Company Description and Business Overview 12.3.3 Natural Killer Cells Therapeutics Introduction 12.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.3.5 Fate Therapeutics Recent Development 12.4 Fortress Biotech 12.4.1 Fortress Biotech Company Details 12.4.2 Company Description and Business Overview 12.4.3 Natural Killer Cells Therapeutics Introduction 12.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.4.5 Fortress Biotech Recent Development 12.5 Glycostem Therapeutics 12.5.1 Glycostem Therapeutics Company Details 12.5.2 Company Description and Business Overview 12.5.3 Natural Killer Cells Therapeutics Introduction 12.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.5.5 Glycostem Therapeutics Recent Development 12.6 Innate Pharma 12.6.1 Innate Pharma Company Details 12.6.2 Company Description and Business Overview 12.6.3 Natural Killer Cells Therapeutics Introduction 12.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.6.5 Innate Pharma Recent Development 12.7 Nantkwest 12.7.1 Nantkwest Company Details 12.7.2 Company Description and Business Overview 12.7.3 Natural Killer Cells Therapeutics Introduction 12.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.7.5 Nantkwest Recent Development 12.8 Nkarta Therapeutics 12.8.1 Nkarta Therapeutics Company Details 12.8.2 Company Description and Business Overview 12.8.3 Natural Killer Cells Therapeutics Introduction 12.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.8.5 Nkarta Therapeutics Recent Development 12.9 NKT Therapeutics 12.9.1 NKT Therapeutics Company Details 12.9.2 Company Description and Business Overview 12.9.3 Natural Killer Cells Therapeutics Introduction 12.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.9.5 NKT Therapeutics Recent Development 12.10 Ziopharm Oncology 12.10.1 Ziopharm Oncology Company Details 12.10.2 Company Description and Business Overview 12.10.3 Natural Killer Cells Therapeutics Introduction 12.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2014-2019) 12.10.5 Ziopharm Oncology Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Natural Killer Cells Therapeutics Key Market Segments Table Key Players Natural Killer Cells Therapeutics Covered Table Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer NK Cell Therapies Figures Table Key Players of NK Cell Therapies Figuer NK Cell Directed Antibodies Figures Table Key Players of NK Cell Directed Antibodies Table Global Natural Killer Cells Therapeutics Market Size Growth by Application 2019-2025 (Million US$) Figure Global Natural Killer Cells Therapeutics Market Share by Application in 2018 & 2025 Figure Cancer Case Studies Figure Gastrointestinal Diseases Case Studies Figure Immunoproliferative Disorders Case Studies Figure Others Case Studies Figure Natural Killer Cells Therapeutics Report Years Considered Figure Global Natural Killer Cells Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Natural Killer Cells Therapeutics Market Size by Regions 2019-2025 (Million US$) Table Global Natural Killer Cells Therapeutics Market Size by Regions 2019-2025 (Million US$) Table Global Natural Killer Cells Therapeutics Market Share by Regions 2014-2019 Figure Global Natural Killer Cells Therapeutics Market Share by Regions 2014-2019 Figure Global Natural Killer Cells Therapeutics Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Natural Killer Cells Therapeutics Revenue by by Players (2014-2019) (Million US$) Table Global Natural Killer Cells Therapeutics Market Share by by Players (2014-2019) Figure Global Natural Killer Cells Therapeutics Market Share by by Players in 2018 Table Global Natural Killer Cells Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Natural Killer Cells Therapeutics Product/Solution/Service Table Date of Enter into Natural Killer Cells Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Natural Killer Cells Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Natural Killer Cells Therapeutics Market Size Share by Type (2014-2019) Figure Global Natural Killer Cells Therapeutics Market Size Market Share by Type (2014-2019) Table Global Natural Killer Cells Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Natural Killer Cells Therapeutics Market Size Share by Application (2014-2019) Figure Global Natural Killer Cells Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Natural Killer Cells Therapeutics Revenue Market Share by Application in 2018 Figure North America Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$) Table North America Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$) Table North America Key Players Natural Killer Cells Therapeutics Market Share (2018-2019) Table North America Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$) Table North America Natural Killer Cells Therapeutics Market Share by Type 2014-2019 Table North America Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$) Table North America Natural Killer Cells Therapeutics Market Share by Application 2014-2019 Figure Europe Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Natural Killer Cells Therapeutics Market Share (2018-2019) Table Europe Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$) Table Europe Natural Killer Cells Therapeutics Market Share by Type 2014-2019 Table Europe Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$) Table Europe Natural Killer Cells Therapeutics Market Share by Application 2014-2019 Figure China Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Natural Killer Cells Therapeutics Market Share (2018-2019) Table China Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$) Table China Natural Killer Cells Therapeutics Market Share by Type 2014-2019 Table China Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$) Table China Natural Killer Cells Therapeutics Market Share by Application 2014-2019 Figure Japan Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Natural Killer Cells Therapeutics Market Share (2018-2019) Table Japan Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$) Table Japan Natural Killer Cells Therapeutics Market Share by Type 2014-2019 Table Japan Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$) Table Japan Natural Killer Cells Therapeutics Market Share by Application 2014-2019 Figure Southeast Asia Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Natural Killer Cells Therapeutics Market Share (2018-2019) Table Southeast Asia Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Natural Killer Cells Therapeutics Market Share by Type 2014-2019 Table Southeast Asia Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Natural Killer Cells Therapeutics Market Share by Application 2014-2019 Figure India Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Natural Killer Cells Therapeutics Market Share (2018-2019) Table India Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$) Table India Natural Killer Cells Therapeutics Market Share by Type 2014-2019 Table India Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$) Table India Natural Killer Cells Therapeutics Market Share by Application 2014-2019 Figure Central & South America Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Natural Killer Cells Therapeutics Market Share (2018-2019) Table Central & South America Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$) Table Central & South America Natural Killer Cells Therapeutics Market Share by Type 2014-2019 Table Central & South America Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$) Table Central & South America Natural Killer Cells Therapeutics Market Share by Application 2014-2019 Table Affimed Company Details Table Affimed Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Affimed Recent Development Table Celgene Company Details Table Celgene Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Celgene Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Celgene Recent Development Table Fate Therapeutics Company Details Table Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Fate Therapeutics Recent Development Table Fortress Biotech Company Details Table Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Fortress Biotech Recent Development Table Glycostem Therapeutics Company Details Table Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Glycostem Therapeutics Recent Development Table Innate Pharma Company Details Table Innate Pharma Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Innate Pharma Recent Development Table Nantkwest Company Details Table Nantkwest Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Nantkwest Recent Development Table Nkarta Therapeutics Company Details Table Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Nkarta Therapeutics Recent Development Table NKT Therapeutics Company Details Table NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table NKT Therapeutics Recent Development Table Ziopharm Oncology Company Details Table Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$) Figure Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019) Table Ziopharm Oncology Recent Development Table Global Natural Killer Cells Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Natural Killer Cells Therapeutics Market Size Share by Regions (2019-2025) Figure Global Natural Killer Cells Therapeutics Market Size Share by Regions in 2025 Figure North America Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Natural Killer Cells Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Natural Killer Cells Therapeutics Market Size by Product (2019-2025) Figure Global Natural Killer Cells Therapeutics Market Size by Product in 2025 Table Global Natural Killer Cells Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Natural Killer Cells Therapeutics Market Size by Application (2019-2025) Figure Global Natural Killer Cells Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Affimed Celgene Fate Therapeutics Fortress Biotech Glycostem Therapeutics Innate Pharma Nantkwest Nkarta Therapeutics NKT Therapeutics Ziopharm Oncology
  • PRICE
  • $3900
    $7800

Our Clients